Content Type: Commentary & Opinion

Introduction to a Supplement on Innovative Approaches to Studying Health Outcomes in Rare Diseases

March 16, 2026

Insights From a National Conference: “Conflicts of Interest in the Practice of Medicine”

March 16, 2026

Reforming the World Health Organization’s Essential Medicines List: Essential but Unaffordable

March 16, 2026

Paying for Prescription Drugs in the New Administration

March 16, 2026

Promoting Patient Interests in Implementing the Federal Right to Try Act

March 16, 2026

Translational Research and the U.S. Federal Elections

March 16, 2026

Development of a National Public Pharmaceutical Research and Development Institute

March 16, 2026

Switching to Over-The-Counter Availability of Rescue Inhalers for Asthma

March 16, 2026

The Case for Reforming Drug Naming: Should Brand Name Trademark Protections Expire Upon Generic Entry?

March 16, 2026

Preventing Medical-Device-Borne Outbreaks: High-Level Disinfection Policy for Duodenoscopes

March 16, 2026

The 21st Century Cures Act—Will It Take Us Back in Time?

March 16, 2026

The Medical Device Excise Tax—Over Before It Begins?

March 16, 2026